In certain tumour types, like non-small cell lung cancer (NSCLC) and melanoma, the expression of PD-L1 inside the tumour is linked to improved responses to PD-1/PD-L1 checkpoint blockage [14]. Here, CD274 is linked to non-small cell lung carcinoma.